Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases

Skeletal Radiology

Volumn 33, Issue 12, 2004, Pages 732-736

  Fernandes, Joao L ^a   Viana, Sergio L ^b   Rocha, Arthemizio L ^a   Ribeiro, Maria C ^c   Castro, Luis C ^c  

^a Hospital Santa Lucia   (Brazil)

^b Clinica Radiologica Vila Rica   (Brazil)

^c HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

Biphosphonates; Radiography; Sclerotic bands; Skeleton

Indexed keywords

ALENDRONIC ACID; CALCIUM; CHLOROQUINE; CORTICOSTEROID; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; BONE DENSITY; BONE EROSION; BONE MINERAL; BONE RADIOGRAPHY; BONE TURNOVER; CASE REPORT; DISEASE ACTIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; GROWTH RATE; GROWTH RETARDATION; HUMAN; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; MALE; METAPHYSIS; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALENDRONATE; ARTHRITIS, JUVENILE RHEUMATOID; BONE DENSITY; BONE REMODELING; CHILD; DIPHOSPHONATES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OSTEOPOROSIS; TREATMENT OUTCOME;

EID: 8844282631     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-004-0804-8     Document Type: Article

References (12)

1. Cimaz R. Biphosphonates in the pediatric rheumatic diseases. Pediatr Rheumatol Online J April 2003; 1:29-33; available at: http://www.pedrheumonlinejournal.org/April/ClinReview.htm, accessed 14 April,2004
2. Allgrove J. Biphosphonates. Arch Dis Child 1997; 76:73-75 1:STN:280:ByiB3M3jtFc%3D, 9059169
3. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12:1746-1752 1:CAS:528:DyaK2sXmvVSqtLY%3D, 9333137
4. Marini JC. Do biphosphonates make children's bones better or brittle? N Engl J Med 2003; 349:423-426 10.1056/NEJMp038103, 12890840
5. Glorieux FH, Nicholas JB, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with osteogenesis imperfecta. N Engl J Med 1998; 339:947-952 10.1056/NEJM199810013391402, 1:CAS:528:DyaK1cXmslCitrk%3D, 9753709
6. Plotkin H, Rauch F, Nicholas NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000; 85:1846-1850 10.1210/jc.85.5.1846, 1:CAS:528:DC%2BD3cXlt1WlsLw%3D, 10843163
7. Grissom LE, Harcke HT. Radiographic features of biphosphonate therapy in pediatric patients. Pediatr Radiol 2003; 33:226-229 12709749
8. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Biphosphonate-induced osteopetrosis. N Engl J Med 2003; 349:457-463 10.1056/NEJMoa023110, 1:CAS:528:DC%2BD3sXms1Ogsrc%3D, 12890844
9. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996; 39:179-201 8546731
10. Rabinovich EC. Biphosphonates in childhood rheumatic disease - have we opened Pandora's box? Pediatr Rheumatol Online J April 2003; 1:1-3; available at: http://www.pedrheumonlinejournal.org/April/EditoriaBip.html ; accessed 14 April,2004
11. van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of biphosphonates. Radiology 1992; 184:249-254 1609087
12. Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 2000; 83:143-145 10.1136/adc.83.2.143, 1:STN:280:DC%2BD3cvgtVaksg%3D%3D, 10906023